
Publikationen von Mireia Vilardell
Alle Typen
Zeitschriftenartikel (7)
1.
Zeitschriftenartikel
13, S. 623 - 637 (2014)
Testing chemical carcinogenicity by using a transcriptomics HepaRG-based model. Experimental and Clinical Sciences Journal (EXCLI Journal) 2.
Zeitschriftenartikel
2 (8), S. 771 - 778 (2013)
An integrative computational analysis provides evidence for FBN1-associated network de-regulation in trisomy 21. Biology Open 3.
Zeitschriftenartikel
9 (2), S. e1003250 - e1003250 (2013)
DNA–Methylome Analysis of Mouse Intestinal Adenoma Identifies a Tumour-Specific Signature That Is Partly Conserved in Human Colon Cancer. PLoS Genetics 4.
Zeitschriftenartikel
34 (6), S. 1393 - 402 (2013)
Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models. Carcinogenesis 5.
Zeitschriftenartikel
2 (8), S. 771 - 8 (2013)
An integrative computational analysis provides evidence for FBN1-associated network deregulation in trisomy 21. Biol Open 6.
Zeitschriftenartikel
12, S. 229 (2011)
Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes. BMC Genomics 7.
Zeitschriftenartikel
124 (2), S. 278 - 90 (2011)
Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity. Toxicological Sciences: an Official Journal of the Society of Toxicology Buchkapitel (1)
8.
Buchkapitel
Predictive mechanisms in stem cells: an in vitro system based method for testing carcinogenicity. In: Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology, S. 337 - 346 (Hg. Sahu, . C.; Casciano, D. A.). John Wiley & Sons, Ltd, Hoboken, NJ (2014)